DR. AIDEA / SINGAPORE & ASEAN
Independent reporting and analysis on clinical AI, health data, governance and life sciences—written for people making consequential decisions in Singapore and Southeast Asia.
FEATURED / AI & PRIVACY
Every night, millions of people type symptoms, legal questions and private worries into a chatbot. In 2026 that data trail became the subject of lawsuits, Senate testimony and at least one wrongful-death case. Here is what actually happens to it.
8 min read · Singapore & ASEAN
LATEST ANALYSIS
CLINICAL AI
Patient-facing AI can make care more accessible. But safe use depends on its boundaries, the quality of escalation and the clinician’s role.
6 min read
IMPLEMENTATION
Low-code AI is changing who can create healthcare tools—and raising new questions about review, ownership and clinical safety.
7 min read
DIAGNOSTICS
The promise is real. So are the data, validation, workflow and equity questions that determine whether technology improves care.
8 min read
THE WEEKLY BRIEF
One policy shift. One implementation lesson. One development worth your attention.
No hype. No vendor blasts. Unsubscribe anytime.
THE DRAIDEA LENS
01 / CLINICAL REALITY
Does it improve a real workflow, safely?
02 / EVIDENCE
What is known—and what remains unproven?
03 / LOCAL CONTEXT
Will it work in Singapore and ASEAN care settings?
04 / ACCOUNTABILITY
Who is responsible when the system gets it wrong?
ABOUT DR. AIDEA
DR. AIDEA is an independent publication about the real work of healthcare AI: the clinical decisions, data foundations, operating models and governance that determine whether technology creates value or merely creates noise.
We write for healthcare, medtech and life-sciences leaders across Singapore and Southeast Asia.